Cannara Biotech Inc. (LOVE.V)

0.8600 -0.0100 (-1.15%) As of 03:06PM EDT. Market open.

Cannara Biotech Inc.

333 Decarie Blvd.
Suite 200
Saint-Laurent, QC H4N 3M9
Canada
514-543-4200
https://cannara.ca

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Zohar Krivorot	CEO & Chairman	300k	N/A	1977
Mr. Nicholas Sosiak C.A., CPA	Chief Financial Officer	240k	N/A	N/A
Mr. Avi Krivorot	Chief Technology Officer	300k	N/A	N/A
Mr. Anthony Manouk	VP of Compliance & GM	160k	N/A	N/A
Mr. Brian Sherman	General Counsel & VP Legal Affairs	N/A	N/A	N/A
Mr. David Abitbol	Vice President of Marketing	N/A	N/A	N/A
Scott Carroll	Vice President of Marketing & Sales	N/A	N/A	N/A
Ms. France Landry	Vice President of Human Resources	N/A	N/A	N/A
Ms. Julia Bouvet	Chief of Staff	N/A	N/A	N/A
Etienne Ledoux	Executive Officer	300k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Corporate Governance

Cannara Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.